AbbVie Inc (ABBV)
175.58
+4.06
(+2.37%)
USD |
NYSE |
Dec 20, 16:00
175.50
-0.08
(-0.05%)
After-Hours: 20:00
AbbVie Free Cash Flow: 15.62B for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen Inc | 6.283B |
| Johnson & Johnson | 19.02B |
| Eli Lilly and Co | -2.275B |
| Merck & Co Inc | 14.84B |
| Pfizer Inc | 8.227B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 5.447B |
| Cash from Investing (Quarterly) | -8.256B |
| Cash from Financing (Quarterly) | -3.072B |
| Free Cash Flow Per Share (Quarterly) | 2.933 |
| Free Cash Flow to Equity (Quarterly) | 4.753B |
| Free Cash Flow to Firm (Quarterly) | 5.642B |
| Free Cash Flow Yield | 5.02% |